Eterna Therapeutics Inc. (NTN) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K/A	10-K	10-K	10-K	10-K	10-K
Total revenues [+]	0.0	0.0	0.0	19.8	23.3	28.0	22.3	24.5
Subscription							17.5	17.1
Other							3.6	3.3
Other income								0.2
Revenue growth			-100.0%	-15.1%	-16.7%	25.6%	-9.0%	-5.9%
Cost of goods sold	0.0	0.0	0.0	7.5	8.1	6.8	7.7	12.6
Gross profit	0.0	0.0	0.0	12.3	15.3	21.3	14.6	11.9
Gross margin				62.2%	65.4%	75.9%	65.4%	48.7%
Selling, general and administrative [+]	16.8	14.7	3.3	13.2	14.5	15.6	16.5	18.1
General and administrative	16.8	14.7	3.3
Research and development	10.4	12.7	4.0
Other operating expenses		15.4		0.6	0.0	6.8		0.3
EBITDA [+]	-27.1	-42.7	-7.2	1.1	3.2	0.9	0.6	-3.8
EBITDA growth	-36.7%	497.6%	-741.3%	-65.5%	252.8%	50.2%	-116.1%	185.3%
EBITDA margin				5.6%	13.8%	3.3%	2.7%	-15.5%
Depreciation	0.2	0.1	0.1	2.9	2.8	2.3	2.8	3.1
EBITA	-27.2	-42.8	-7.2	-1.8	0.5	-1.4	-2.2	-6.8
EBITA margin				-8.9%	2.0%	-5.0%	-10.0%	-27.9%
Amortization of intangibles							0.1	0.1
EBIT [+]	-27.2	-42.8	-7.2	-1.8	0.5	-1.4	-2.3	-6.9
EBIT growth	-36.4%	491.1%	311.4%	-479.7%	-133.1%	-38.5%	-67.0%	69.2%
EBIT margin				-8.9%	2.0%	-5.0%	-10.2%	-28.1%
Non-recurring items [+]	6.0	70.9			0.3
Asset impairment	6.0				0.3
In-process research & development		80.5
Interest expense, net [+]				0.2	0.4	0.5	0.6	0.0
Interest expense				0.2	0.4	0.5	0.6	0.3
Interest income								0.0
Other income (expense), net [+]	8.7	-8.7	0.0	0.0	-0.1	0.9	0.0	0.0
Other	-1.2	0.9	0.0	-0.3	-0.5	-0.9	0.0	-0.3
Pre-tax income	-24.5	-122.5	-7.3	-2.0	-0.3	-1.0	-2.9	-7.2
Income taxes	0.0	0.1	0.0	0.0	-0.1	0.1	0.0	0.0
Tax rate			0.0%		19.8%
Net income	-24.6	-122.6	-7.3	-2.1	-0.3	-1.1	-2.9	-7.2
Net margin				-10.4%	-1.2%	-3.9%	-13.1%	-29.5%

Basic EPS [+]	($8.06)	($56.61)	($0.41)	($0.72)	($0.10)	($0.45)	($1.54)	($3.93)
Growth	-85.8%	13556.0%	-42.2%	601.4%	-77.1%	-70.9%	-60.9%	6745.3%
Diluted EPS [+]	($8.06)	($56.61)	($0.41)	($0.72)	($0.10)	($0.45)	($1.54)	($3.93)
Growth	-85.8%	13556.0%	-42.2%	601.4%	-77.1%	-70.9%	-60.9%	6745.3%


Shares outstanding (basic) [+]	3.1	2.2	17.6	2.9	2.7	2.4	1.9	1.8
Growth	40.9%	-87.7%	511.8%	7.0%	10.1%	28.3%	3.5%	-97.9%
Shares outstanding (diluted) [+]	3.1	2.2	17.6	2.9	2.7	2.4	1.9	1.8
Growth	40.9%	-87.7%	511.8%	7.0%	10.1%	28.3%	3.5%	-97.9%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.